1 Min Read
June 1 (Reuters) - Claris Lifesciences Ltd:
* Says underwent a successful USFDA Pharmacovigilance (PV) audit from Monday 29th may to Wednesday 31st May with no observation
Source text for Eikon:
Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.